Publication:
Hormone therapy with estrogens and gestagens in peri- and post-menopause

dc.bibliographiccitation.firstpage553
dc.bibliographiccitation.issue5
dc.bibliographiccitation.journalDer Internist
dc.bibliographiccitation.lastpage558
dc.bibliographiccitation.volume49
dc.contributor.authorEmons, G.
dc.date.accessioned2018-11-07T11:15:34Z
dc.date.available2018-11-07T11:15:34Z
dc.date.issued2008
dc.description.abstractHormone therapy with estrogens (combined with progestin for women who have not been hysterectomized) is the most efficacious treatment for climacteric symptoms. A few years ago hormone therapy was considered to be an ideal prevention for cardio-vascular disease, osteoporosis, dementia and other diseases. Large prospective randomized trials have changed this paradigm. Hormone therapy should only be used with a clear indication (moderate to severe climacteric symptoms and - with limitations - prevention of osteoporosis). The lowest effective dose should be used for the shortest possible time.
dc.identifier.doi10.1007/s00108-008-2107-y
dc.identifier.isi000255627000005
dc.identifier.pmid18345528
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/54394
dc.notes.statuszu prüfen
dc.notes.submitterNajko
dc.publisherSpringer
dc.relation.issn0020-9554
dc.titleHormone therapy with estrogens and gestagens in peri- and post-menopause
dc.typejournal_article
dc.type.internalPublicationyes
dc.type.peerReviewedyes
dc.type.statuspublished
dspace.entity.typePublication

Files

Collections